[go: up one dir, main page]

AR026038A1 - Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion - Google Patents

Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion

Info

Publication number
AR026038A1
AR026038A1 ARP000105396A ARP000105396A AR026038A1 AR 026038 A1 AR026038 A1 AR 026038A1 AR P000105396 A ARP000105396 A AR P000105396A AR P000105396 A ARP000105396 A AR P000105396A AR 026038 A1 AR026038 A1 AR 026038A1
Authority
AR
Argentina
Prior art keywords
acid
transdermal therapeutic
therapeutic system
administration
manufacturing process
Prior art date
Application number
ARP000105396A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR026038A1 publication Critical patent/AR026038A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Un sistema terapéutico transdermal en forma de aposito que contiene ácido acetilsalicílico y/o ácido salicílico, con una capa superior, un reservorio deprincipio activo unido a ella, una membrana de control de la transferencia del principio activoen ausencia de otros mecanismos de control, una disposicionadhesiva por contacto para la fijacion del sistema sobre la piel y una capa protectora amovible antes de la aplicacion, caracterizado por contener al menos uncomponente del grupo de losderivad os del pirrol y al menos un componente del grupo de los terpenos.
ARP000105396A 1999-10-13 2000-10-13 Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion AR026038A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19949202A DE19949202A1 (de) 1999-10-13 1999-10-13 Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure

Publications (1)

Publication Number Publication Date
AR026038A1 true AR026038A1 (es) 2002-12-26

Family

ID=7925396

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105396A AR026038A1 (es) 1999-10-13 2000-10-13 Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion

Country Status (8)

Country Link
EP (1) EP1220661B1 (es)
JP (1) JP4938949B2 (es)
AR (1) AR026038A1 (es)
AT (1) ATE309792T1 (es)
AU (1) AU7660900A (es)
DE (2) DE19949202A1 (es)
ES (1) ES2253257T3 (es)
WO (1) WO2001026637A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
JP4116447B2 (ja) 2001-05-01 2008-07-09 エイ．ブイ．トップチーブ インスティテュート オブ ペトロケミカル シンセシス ヒドロゲル組成物
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
CA2453013C (en) 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
CA2530996C (en) 2003-07-03 2013-05-07 Corium International, Inc. Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
US8658201B2 (en) 2004-01-30 2014-02-25 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
WO2006017807A2 (en) 2004-08-05 2006-02-16 Corium International, Inc. Adhesive composition
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
WO2022182738A1 (en) * 2021-02-23 2022-09-01 Nanomed Skincare, Inc. Method of administering a dual therapeutic and cosmetic agent

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
JP2651616B2 (ja) * 1989-02-03 1997-09-10 リンテック株式会社 経皮吸収製剤
JPH0525045A (ja) * 1991-07-18 1993-02-02 Tanabe Seiyaku Co Ltd 経皮吸収製剤
EP0682942A4 (en) * 1993-01-21 1996-12-04 Yamanouchi Pharma Co Ltd NEW ABSORBABLE PERCUTANEOUS PREPARATION.
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
JP3496169B2 (ja) * 1994-10-17 2004-02-09 大協薬品工業株式会社 硬膏剤及びその製造法
JPH08291068A (ja) * 1995-04-21 1996-11-05 Sekisui Chem Co Ltd エペリゾン外用貼付剤
JPH0977902A (ja) * 1995-09-12 1997-03-25 Shinko Refine Kk 発泡ポリスチレンの減容液原液組成物
DE19701059C2 (de) * 1997-01-15 2000-12-21 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes transdermales therapeutisches System mit Resorptionsverstärkung
JPH10279727A (ja) * 1997-04-08 1998-10-20 Shinko Refine Kk 減容化済み発泡ポリスチレンから減容液を分離する方法
JPH11222443A (ja) * 1997-11-11 1999-08-17 Saitama Daiichi Seiyaku Kk 経皮吸収促進組成物および経皮吸収製剤
JPH11209797A (ja) * 1998-01-27 1999-08-03 Shogo Omae クリーニング剤

Also Published As

Publication number Publication date
AU7660900A (en) 2001-04-23
EP1220661B1 (de) 2005-11-16
JP2003511408A (ja) 2003-03-25
WO2001026637A3 (de) 2001-12-13
EP1220661A2 (de) 2002-07-10
DE50011653D1 (de) 2005-12-22
ATE309792T1 (de) 2005-12-15
ES2253257T3 (es) 2006-06-01
DE19949202A1 (de) 2001-05-03
JP4938949B2 (ja) 2012-05-23
WO2001026637A2 (de) 2001-04-19

Similar Documents

Publication Publication Date Title
ES2581574T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
AR026038A1 (es) Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion
AR012790A1 (es) Un articulo absorbente para absorcion de fluidos corporales y metodo para ayudar a mantener la piel de un usuario a un ph acido.
ES2176234T3 (es) Sistema terapeutico transdermal con galantamina como componente activo.
ES2137993T3 (es) La utilizacion de glicerina para moderar el aporte transdermico de medicamentos.
BRPI0212028B8 (pt) sistema terapêutico transdérmico (tts) e seu processo de produção
AR021371A1 (es) Aposito
AR026040A1 (es) Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel
KR890701164A (ko) 피부침투성 치료 시스템
AR005281A1 (es) Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
ES2116572T3 (es) Parche para la administracion percutanea de sustancias de contenido quimicamente basico, farmaceuticamente eficaces y volatiles, y un metodo para su fabricacion.
MX2020000651A (es) Sistema de administracion transdermica con una membrana microporosa que tiene poros llenos de solvente.
AR093940A1 (es) Sistema de liberacion transdermica, metodo de preparacion
ES2194736T3 (es) Sistema de microdepositos sobre la base de polisiloxanos y disolvente ambifilos.
DK324687A (da) Transdermalt farmeceutisk praeparat
AR014493A1 (es) Parche apto para liberar la piel de las impurezas que presenta, el cual comprende, sobre un soporte, una matriz polimerica que contiene por lo menos un principi activo, siendo adhesiva la superficie del parche destinada a estar en contacto con la piel.
AR088072A1 (es) Articulo absorbente
ES2130446T3 (es) Sistema terapeutico transdermico que contiene octildodecanol como inhibidor de cristalizacion.
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
ES2007240A6 (es) Procedimiento para elaborar un preparado farmaceutico que asegura la absorcion transdernal del ingrediente activo.
RU2018146249A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
ES2160727T3 (es) Parches medicinales para administracion percutanea.
ES2058627T3 (es) Sistema terapeutico para la administracion retardada y dirigida a traves de la piel o de las mucosas de sustancias activas.
ES2174492T3 (es) Sistema de administracion transdermica con escopolamina base como principio activo.